eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Middle Ear & Mastoid

Middle Ear, Ossiculoplasty: Workup

Author: Robert A Battista, MD, FACS, Assistant Professor of Otolaryngology, Northwestern University Medical School; Consulting Staff, Ear Institute of Chicago, LLC
Coauthor(s): Carlos Esquivel, MD, Consulting Staff, Department of Surgery, Neuro-Otology and Skull Base Surgery, Madigan Army Medical Center
Contributor Information and Disclosures

Updated: Feb 18, 2008

Workup

Imaging Studies

  • A thin-section CT scan of the temporal bones with axial and coronal views may provide the following information:
    • Extent of cholesteatoma or chronic ear disease (if present)
    • Size of the middle ear cavity
    • Presence, absence, and continuity of the ossicular chain
    • Presence of attic fixation of the malleus
    • Presence of otosclerosis
    • Bony structure of the inner ear
  • The decision to perform a CT scan is based on the patient's history and physical examination findings. The final decision to perform a CT scan is at the discretion of the examining physician.

Diagnostic Procedures

  • Perform a thorough otoscopic examination, preferably with binocular microscopy.
  • Inspect the preauricular skin and auricle. The presence of preauricular pits or tags or auricular deformities may suggest a congenital abnormality.
  • Examine the external auditory canal for size, shape, and defects.
  • Note the status of the tympanic membrane and, as much as possible, the middle ear.
  • Perform pure tone audiometry with air/bone thresholds and masking, if necessary, prior to surgical planning. Include acoustic reflexes. The presence of acoustic reflexes with a conductive hearing loss may be associated with inner ear conductive hearing loss.

Histologic Findings

Middle ear implants are unique in that one end must be coupled to the tympanic membrane and the other to bone or soft tissue. Ideally, the implant should not contact other tissue between the implant's 2 ends. The material also must maintain its shape, rigidity, and acoustic transmission properties. The outcome of middle ear implantation is determined largely by the status of the middle ear. Eustachian tube dysfunction can lead to early extrusion, and infection can lead to breakdown and resorption of an implant.

Ossicular reconstruction materials are divided into autografts, homografts, or alloplastic prosthetics. Each of these materials possesses unique properties when exposed to the environment of the middle ear. Similarly, unique problems are associated with each of these materials. Problems include graft failure, implant extrusion, and persistent or recurrent conductive hearing loss.

Autologous cartilage was one of the first materials used for ossicular chain reconstruction. In 1971, Smyth reported that cartilage struts removed at revision surgery showed erosion, suggesting the graft would not be stable over time (<3 y).2 Similar work by Merchant and Nadol in 1994 showed loss of rigidity on microscopic examination, chondromalacia on histologic examination, and resorption.3 The loss of stiffness is probably due to ingrowth of blood vessels with subsequent chondritis. These findings led the authors to conclude that cartilage struts are unsatisfactory as long-term implants.

Autologous incus grafts also have been used for some time. A strut or crutch in the short process of the incus is created for the malleus, with a cup made for the stapes capitulum. Autograft ossicular struts maintain their contour, shape, size, and physical integrity for at least 11 years.3 Ossicular grafts eventually may become nonvital because of loss of blood supply. Thermal injury during sculpturing may contribute to the loss of blood supply. Autologous ossicles subsequently undergo new bone formation and remodeling. The process is characterized by a slow creeping substitution of revascularized bone. The neo-osteogenesis is not vital for the transmission of sound.

Plasti-Pore, a HDPS, is an alloplastic material with a long clinical history. This material sets the standard by which the National Bureau of Standards tests other implant materials. HDPS has nonreactive properties and sufficient porosity to encourage tissue ingrowth.

Histologic examination of HDPS implanted for 1-4 years has shown extensive invasion of the porous spaces with fibrocytes, small round cells, and foreign-body giant cells. An envelope of fibrous tissue with a lining membrane of mucosal epithelium often forms around the implant. Some studies have demonstrated partial resorption of HDPS and replacement by fibrous tissue.

Clinical experience has shown the necessity of covering these HDPS alloplasts with cartilage to minimize the incidence of extrusion. Extrusion rates have averaged 3-5% in large series with 5-10 years of follow-up monitoring. Although most extrusions have occurred within the first year, some extrusions have occurred up to 5 years postoperatively.

Hydroxylapatite is currently one of the most common alloplastic materials used for ossicular reconstruction. Hydroxylapatite is a polycrystalline calcium phosphate ceramic that has the same chemical composition as bone. This material chemically attaches to bone and is osteoconductive. It forms a direct bond with bone at the hydroxylapatite/tissue interface. This bond is associated with an electron-dense layer at the interface composed, at least in part, of calcium phosphate in the form of hydroxylapatite. This epitaxy or continuity between the artificial and biologic hydroxylapatite crystals might explain the bonding osteogenesis at the interface. If placed next to the scutum, osseointegration can occur, with subsequent conductive hearing loss. Cartilage is not required when using hydroxylapatite.

Within the first 2 weeks of implantation, a large proportion of hydroxylapatite implants are covered with an epithelial layer. With time, the implant gradually becomes completely covered by this epithelial layer. The final epithelial layer contains all cell types characteristic for the middle ear. An epithelial covering resembling that in the normal middle ear indicates good biocompatibility of an implant material.

Hydroxylapatite is produced in both porous (pore size >100 µm) and dense (pore size <30 µm) forms. The dense form is the type used in ossicular prosthetics. The size of the macropore has a direct influence on the kind of tissue that grows into these pores. Generally, a pore size larger than 100 µm favors the ingrowth of bone, whereas a pore size of 30 µm allows fibrous tissue ingrowth. With the porous implant materials, a firmer fixation and a smaller fibrous capsule occur compared to the dense form.

Titanium is another common alloplastic material. Studies in rabbits have shown that within 28 days after implantation, a thin, noninflamed, even layer of epithelium forms over the inserted implant. Similar results in human studies have shown the same type of reactivity. Titanium forms a biostable titanium oxide layer when combined with oxygen. Titanium has shown significant biostability in the middle ear for the past decade.

The properties of titanium make it possible to manufacture an extremely fine and light prosthesis with substantial rigidity in the shaft. Furthermore, differential processing of the material surfaces triggers various tissue reactions. For example, if titanium implants are rough milled, their contact points are increased. Rough-milled surfaces are most appropriate in areas that contact cartilage or the stapes head or footplate. Conversely, the smoother the surface, the less connective tissue reaction occurs, and the epithelial covering is minimized.

More on Middle Ear, Ossiculoplasty

Overview: Middle Ear, Ossiculoplasty
Workup: Middle Ear, Ossiculoplasty
Treatment: Middle Ear, Ossiculoplasty
Follow-up: Middle Ear, Ossiculoplasty
Multimedia: Middle Ear, Ossiculoplasty
References

References

  1. Merchant SN, Ravicz ME, Puria S, Voss SE, Whittemore KR Jr, Peake WT, et al. Analysis of middle ear mechanics and application to diseased and reconstructed ears. Am J Otol. Mar 1997;18(2):139-54. [Medline].

  2. Smyth G. Long term results of middle ear reconstructive surgery. J Laryngol Otol. Dec 1971;85(12):1227-30. [Medline].

  3. Merchant SN, Nadol JB Jr. Histopathology of ossicular implants. Otolaryngol Clin North Am. Aug 1994;27(4):813-33. [Medline].

  4. Feghali JG, Barrs DM, Beatty CW, Chen DA, Green JD Jr, Krueger WW, et al. Bone cement reconstruction of the ossicular chain: a preliminary report. Laryngoscope. Jun 1998;108(6):829-36. [Medline].

  5. Huttenbrink KB, Zahnert T, Wustenberg EG, Hofmann G. Titanium clip prosthesis. Otol Neurotol. Jul 2004;25(4):436-42. [Medline].

  6. Zahnert T, Huttenbrink KB, Murbe D, Bornitz M. Experimental investigations of the use of cartilage in tympanic membrane reconstruction. Am J Otol. May 2000;21(3):322-8. [Medline].

  7. Goldenberg RA, Driver M. Long-term results with hydroxylapatite middle ear implants. Otolaryngol Head Neck Surg. May 2000;122(5):635-42. [Medline].

  8. Albu S, Babighian G, Trabalzini F. Prognostic factors in tympanoplasty. Am J Otol. Mar 1998;19(2):136-40. [Medline].

  9. Bayazit AY. Practical use of total and partial ossicular replacement prosthesis in ossiculoplasty. Laryngoscope. Jan 2000;110(1):176-7. [Medline].

  10. Bojrab DI, Causse JB, Battista RA, Vincent R, Gratacap B, Vandeventer G. Ossiculoplasty with composite prostheses. Overview and analysis. Otolaryngol Clin North Am. Aug 1994;27(4):759-76. [Medline].

  11. Brackmann DE. Porous polyethylene prosthesis: continuing experience. Ann Otol Rhinol Laryngol. Jan-Feb 1986;95(1 Pt 1):76-7. [Medline].

  12. Colletti V, Fiorino FG. Malleus-to-footplate prosthetic interposition: experience with 265 patients. Otolaryngol Head Neck Surg. Mar 1999;120(3):437-44. [Medline].

  13. Cura O, Kriazli T, Oztop F. Can homograft ossicles still be used in ossiculoplasty?. Rev Laryngol Otol Rhinol (Bord). 2000;121(2):87-90. [Medline].

  14. Daniels RL, Rizer FM, Schuring AG, Lippy WL. Partial ossicular reconstruction in children: a review of 62 operations. Laryngoscope. Nov 1998;108(11 Pt 1):1674-81. [Medline].

  15. De la Cruz A, Doyle KJ. Ossiculoplasty in congenital hearing loss. Otolaryngol Clin North Am. Aug 1994;27(4):799-811. [Medline].

  16. Glasscock ME 3rd, Jackson CG, Knox GW. Can acquired immunodeficiency syndrome and Creutzfeldt-Jakob disease be transmitted via otologic homografts?. Arch Otolaryngol Head Neck Surg. Nov 1988;114(11):1252-5. [Medline].

  17. Goldenberg RA. Ossiculoplasty with composite prostheses. PORP and TORP. Otolaryngol Clin North Am. Aug 1994;27(4):727-45. [Medline].

  18. Goode RL, Nishihara S. Experimental models of ossiculoplasty. Otolaryngol Clin North Am. Aug 1994;27(4):663-75. [Medline].

  19. Jahnke K, Plester D, Heimke G. Experiences with Al2O3--ceramic middle ear implants. Biomaterials. Apr 1983;4(2):137-8. [Medline].

  20. Kerr AG, Byrne JE, Smyth GD. Cartilage homografts in the middle ear: a long-term histological study. J Laryngol Otol. Dec 1973;87(12):1193-9. [Medline].

  21. Maassen MM, Zenner HP. Tympanoplasty type II with ionomeric cement and titanium-gold-angle prostheses. Am J Otol. Nov 1998;19(6):693-9. [Medline].

  22. McElveen JT Jr, Feghali JG, Barrs DM, Shelton C, Green JD Jr, Horn KL, et al. Ossiculoplasty with polymaleinate ionomeric prosthesis. Otolaryngol Head Neck Surg. Oct 1995;113(4):420-6. [Medline].

  23. Moretz WH. Ossiculoplasty with an intact stapes: superstructure versus footplate prosthesis placement. Laryngoscope. Nov 1998;108(11 Pt 2 Suppl 89):1-12. [Medline].

  24. Murugasu E, Puria S, Roberson JB Jr. Malleus-to-footplate versus malleus-to-stapes-head ossicular reconstruction prostheses: temporal bone pressure gain measurements and clinical audiological data. Otol Neurotol. Jul 2005;26(4):572-82. [Medline].

  25. Schuknecht HF, Shi SR. Surgical pathology of middle ear implants. Laryngoscope. Mar 1985;95(3):249-58. [Medline].

  26. Schwetschenau EL, Isaacson G. Ossiculoplasty in young children with the Applebaum incudostapedial joint prosthesis. Laryngoscope. Oct 1999;109(10):1621-5. [Medline].

  27. van Blitterswijk CA, Grote JJ, Koerten HK, Kuijpers W. The biological performance of calcium phosphate ceramics in an infected implantation site. III: Biological performance of beta-whitlockite in the noninfected and infected rat middle ear. J Biomed Mater Res. Oct 1986;20(8):1197-217. [Medline].

  28. Vincent R, Lopez A, Sperling NM. Malleus ankylosis: a clinical, audiometric, histologic, and surgical study of 123 cases. Am J Otol. Nov 1999;20(6):717-25. [Medline].

  29. Wang X, Song J, Wang H. Results of tympanoplasty with titanium prostheses. Otolaryngol Head Neck Surg. Nov 1999;121(5):606-9. [Medline].

  30. Wehrs RE. Incus interposition and ossiculoplasty with hydroxyapatite prostheses. Otolaryngol Clin North Am. Aug 1994;27(4):677-88. [Medline].

Further Reading

Keywords

ossicular chain reconstruction, autografts, homografts, alloplastic prosthetics, ossicle, high-density polyethylene sponge, HDPS, hydroxylapatite, Middle Ear Risk index, MER index, prosthesis, partial ossicular reconstruction prosthesis, PORP, total ossicular reconstruction prosthesis, TORP, ossicular reconstruction, ossiculoplasty of the middle ear, ossiculoplasty, chronic otitis media, ossicular damage, middle ear

Contributor Information and Disclosures

Author

Robert A Battista, MD, FACS, Assistant Professor of Otolaryngology, Northwestern University Medical School; Consulting Staff, Ear Institute of Chicago, LLC
Robert A Battista, MD, FACS is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Neurotology Society, and Illinois State Medical Society
Disclosure: Nothing to disclose.

Coauthor(s)

Carlos Esquivel, MD, Consulting Staff, Department of Surgery, Neuro-Otology and Skull Base Surgery, Madigan Army Medical Center
Carlos Esquivel, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery
Disclosure: Nothing to disclose.

Medical Editor

Jack A Shohet, MD, Chairman of Otolaryngology, Hoag Hospital
Jack A Shohet, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Medical Association, American Neurotology Society, American Tinnitus Association, and California Medical Association
Disclosure: Envoy Medical Consulting fee Consulting

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Peter S Roland, MD, Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director of Clinical Center for Auditory, Vestibular and Facial Nerve Disorders, Chief of Pediatric Otology, University of Texas Southwestern Medical Center; Adjunct Professor of Communicative Disorders, School of Human Development.
Peter S Roland, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American Laryngological Rhinological and Otological Society, American Neurotology Society, American Otological Society, North American Skull Base Society, and Society of University Otolaryngologists-Head and Neck Surgeons
Disclosure: Alcon labs Honoraria Speaking and teaching; GSK Honoraria Speaking and teaching; Advanced Bionics Honoraria Board membership; Cochlear corp Honoraria Board membership; Med El corp travel grants Speaking and teaching; Insight vision Consulting fee Consulting

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Advanced Headache Intervention Consulting fee Consulting; Covidien Corp Consulting fee Consulting

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.